Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| ECM-receptor interaction | R-HSA-373711 | map04512 | iproniazid | 3748 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | iproniazid | 3748 | drug-path |
| Colorectal cancer | R-HSA-4791275 | map05210 | iproniazid | 3748 | drug-path |
| Small cell lung cancer | R-HSA-5619066 | map05222 | iproniazid | 3748 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | iproniazid | 3748 | drug-path |
| RNA polymerase | R-HSA-73864 | map03020 | iproniazid | 3748 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | mafenide | 71203 | drug-path |
| Chemokine signaling pathway | R-HSA-168638 | map04062 | mafenide | 71203 | drug-path |
| Phosphatidylinositol signaling system | R-HSA-1280215 | map04070 | mafenide | 71203 | drug-path |
| Natural killer cell mediated cytotoxicity | R-HSA-5218921 | map04650 | mafenide | 71203 | drug-path |
| p53 signaling pathway | R-HSA-168638 | map04115 | mafenide | 71203 | drug-path |
| Chronic myeloid leukemia | R-HSA-9680350 | map05220 | mafenide | 71203 | drug-path |
| Alzheimer's disease | R-HSA-1643685 | 0 | SC-560 | 643606 | drug-path |
| Huntington's disease | R-HSA-1643685 | 0 | SC-560 | 643606 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | SC-560 | 643606 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | SC-560 | 643606 | drug-path |
| Circadian rhythm - mammal | R-HSA-400253 | 0 | SC-560 | 643606 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | SC-560 | 643606 | drug-path |
| Pathways in cancer | R-HSA-9824443 | map05200 | SC-560 | 643606 | drug-path |
| Insulin signaling pathway | R-HSA-74752 | map04910 | SC-560 | 643606 | drug-path |